Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Dr. Reddy’s Laboratories announced the launch of Memantine HCI Tablets, the generic version of Actavis’ Namenda.
Namenda is an NMDA receptor antagonist approved for the treatment of moderate-to-severe dementia of the Alzheimer’s type. It is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels.
RELATED: Alzheimer’s Drug Won’t Be Discontinued After All
Memantine HCI Tablets are available as 5mg strength tablets in 60-count bottles and 10mg strength tablets in 60- and 500-count bottles.
For more information call (866) 733-3952 or visit DrReddys.com.
Related Content
